Mr Vanash Patel discusses real-world outcomes, learning curves and operational strategies in robotic surgery for colorectal ...

TME is widely accepted as a treatment for stage III and IV rectal cancer, but it comes at the cost of urogenital and anorectal dysfunction, permanent fistulas, and poor quality of life. Local excision ...

PURPOSE: Total mesorectal excision (TME) surgery in the treatment of rectal cancer has been shown to result in a reduction in the number of local recurrences in retrospective studies. Reports on ...

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma Total mesorectal excision (TME) for rectal cancer may result ...

Robotic APR shows better short-term outcomes than laparoscopic APR, with lower positive resection margins and conversion rates to open surgery. Robotic APR is associated with longer operation times ...

Integrating music therapy with anesthesia recovery care enhances recovery in colorectal cancer patients, reducing ...

Patients with localized rectal cancer classified as low risk can skip neoadjuvant chemoradiotherapy (nCRT) with an acceptably low risk of local relapse, new research suggests. A prospective study of ...

Patients with early-stage rectal cancer may be able to forego major surgery — thus preserving their organs and quality of life — with a pre-surgical chemotherapy regimen, according to recent study ...

Some rectal cancer patients might be spared surgery and the lifelong need for a colostomy bag if they undergo MRI screening, a new study finds. The scans might accurately predict which patients have a ...